Back to Search Start Over

PCN137 ECONOMIC BURDEN ASSOCIATED WITH ADVERSE EVENTS AMONG PATIENTS WITH NON-METASTATIC PROSTATE CANCER TREATED WITH BICALUTAMIDE, ENZALUTAMIDE OR ABIRATERONE FOLLOWING ANDROGEN DEPRIVATION THERAPY (SURGICAL/MEDICAL CASTRATION)